Medicare Enrolled
Dr. Charles Marotta, MD
Cardiovascular Disease · Cedar Knolls, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Marotta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marotta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Marotta
Dr. Charles Marotta is a cardiovascular disease specialist in Cedar Knolls, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Marotta performed 12,452 Medicare services across 3,870 unique beneficiaries.
Between the years covered by Open Payments, Dr. Marotta received a total of $14,307 from 35 pharmaceutical and/or device companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Marotta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 1% volume in NJ
$14,307 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,452
Medicare services
Top 1% in NJ for cardiovascular disease
3,870
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~593 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
1,843 | $41 | $125 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
1,842 | $33 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,807 | $102 | $300 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,575 | $12 | $50 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,420 | $44 | $150 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
626 | $7 | $40 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
413 | $34 | $100 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
406 | $22 | $100 |
| Remote physiological data monitoring, 30 days Collection and interpretation of physical parameters transmitted by the patient or caregiver over a 30-day period, requiring at least 30 minutes of professional time. |
364 | $35 | $150 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
344 | $44 | $125 |
| Cardiac rhythm monitor programming Adjustment and configuration of an implanted cardiac rhythm monitoring device to ensure proper operation and data collection. |
228 | $54 | $150 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
227 | $9 | $75 |
| Cardiac rhythm monitor evaluation Review and analysis of data recorded by a cardiac rhythm monitoring device to assess heart activity. |
221 | $44 | $150 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
172 | $150 | $800 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
138 | $55 | $500 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
111 | $139 | $491 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
109 | $402 | $2,000 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
108 | $4 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $115 | $400 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
67 | $20 | $75 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
67 | $773 | $2,000 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
53 | $16 | $50 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
53 | $244 | $375 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
47 | $3,998 | $10,000 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
40 | $47 | $75 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $140 | $400 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
19 | $172 | $350 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
17 | $19 | $100 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
17 | $67 | $150 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
16 | $48 | $150 |
| New patient office visit, complex (60-74 min) | 14 | $171 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.6% high complexity
5.6% medium
92.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,307
Total received (2018-2024)
Avg $2,044/year across 7 years
Top 15% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
300
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,594 (60.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,713 (39.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,022
2023
$1,200
2022
$1,234
2021
$1,424
2020
$334
2019
$4,365
2018
$4,728
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$213
Boston Scientific Corporation
$173
Boehringer Ingelheim Pharmaceuticals, Inc.
$144
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$93
Azurity Pharmaceuticals, Inc.
$62
CVRx, Inc.
$58
Novo Nordisk Inc
$49
Kiniksa Pharmaceuticals International, plc
$45
SANOFI-AVENTIS U.S. LLC
$43
Lexicon Pharmaceuticals, Inc.
$34
AstraZeneca Pharmaceuticals LP
$30
Esperion Therapeutics, Inc.
$30
SCPHARMACEUTICALS INC.
$17
Kowa Pharmaceuticals America, Inc.
$17
Janssen Pharmaceuticals, Inc
$13
Top 3 companies account for 51.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amarin Pharma Inc.
$8,621
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,158
Boston Scientific Corporation
$666
Novartis Pharmaceuticals Corporation
$643
Abbott Laboratories
$580
Novo Nordisk Inc
$285
Janssen Pharmaceuticals, Inc
$264
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$191
SANOFI-AVENTIS U.S. LLC
$188
Amgen Inc.
$181
Kowa Pharmaceuticals America, Inc.
$153
AstraZeneca Pharmaceuticals LP
$134
Merck Sharp & Dohme LLC
$128
Edwards Lifesciences Corporation
$126
E.R. Squibb & Sons, L.L.C.
$115
Bayer Healthcare Pharmaceuticals Inc.
$104
Azurity Pharmaceuticals, Inc.
$95
Esperion Therapeutics, Inc.
$89
Bardy Diagnostics, Inc.
$83
Merck Sharp & Dohme Corporation
$82
CVRx, Inc.
$58
Medtronic, Inc.
$48
Kiniksa Pharmaceuticals International, plc
$45
ATRICURE, INC.
$38
Philips Electronics North America Corporation
$38
Lexicon Pharmaceuticals, Inc.
$34
Althera Pharmaceuticals LLC
$32
Gilead Sciences, Inc.
$25
SCPHARMACEUTICALS INC.
$17
Arbor Pharmaceuticals, Inc.
$16
Kiniksa Pharmaceuticals, Ltd.
$16
PFIZER INC.
$16
Alnylam Pharmaceuticals Inc.
$14
Medicure Pharma Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 73.0% of all-time payments
Associated products mentioned in payments ›
(1653) Diagnostic ECG Service · (5044) MCOT · ATRICLIP LAA EXCLUSION SYSTEM · Arcalyst · Barostim Neo System · CG FUTURE · Carnation Ambulatory Monitor · Confirm Rx · EDARBI · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FUROSCIX · GENERAL THERAPIES · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LIVALO · LUX DX · LifeVest · Livalo · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · ONPATTRO · Ozempic · PRADAXA · PRALUENT · Repatha · Roszet · Rybelsus · SEGLENTIS · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (60%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Cardiologists within 10 mi
588
Per 100K population
115.2
County median income
$134,929
Nearest hospital
GREYSTONE PARK PSYCHIATRIC HOSPITAL
2.1 mi
2.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Marotta is a clinical cardiology specialist, with above-average Medicare volume (top 1% in NJ), with speaking/promotional industry engagement in the top 15% of NJ peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Marotta experienced with remote patient monitoring management, 20 min/month?
Based on Medicare claims data, Dr. Marotta performed 1,843 remote patient monitoring management, 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Marotta receive payments from pharmaceutical companies?
Yes. Dr. Marotta received a total of $14,307 from 35 companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marotta's costs compare to other cardiologists in Cedar Knolls?
Dr. Marotta's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marotta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Cedar Knolls
Browse cardiologists in Cedar Knolls ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology